Documents - Marketing authorisation medicines for human use

52 documents Marketing authorisation medicines for human use

Enter search criteria

Fill in keyword(s) to narrow your search.

Period

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a document or publication you are looking for, such as press releases or speeches.

Only subscribe to documents from this organisation

Product types and fees

The list of product types indicates the various product types handled by the MEB. The choice of the product type determines the ...

Publication | 01-01-2020

Declaration for the package leaflet of parallel imported products

Form | 01-01-2020

MEB 14: Parallel importation: marketing authorisation and maintenance

Parallel import is the importation – and subsequent marketing in the Netherlands – of a medicinal product authorised elsewhere in ...

Policy document | 30-12-2019

GS-list 16

The list of active substances in products that may qualify for sale general sale (GS list) was updated by the MEB on 30 May 2018. ...

Policy document | 17-12-2019

Request for consultation medical device

Form | 21-11-2019

Explanation of the Interest Form - MEB-ZIN Parallel Procedures pilot

Accelerating patient access to reimbursable innovative medicines has been on the wish list of the government, patient ...

Publication | 10-07-2019

List of patient-friendly terms for the package leaflet

In order to optimise the readability of the package leaflet, the MEB has revised the list of patient-friendly terms. The list has ...

Policy document | 28-06-2019

MEB 13: Nomenclature of pharmaceutical products

This document describes the requirements which the marketing authorisation holder has to fulfil when submitting a proposal for a ...

Policy document | 10-05-2019

MEB 21: Statement of ‘abbreviated indications’ on OTC medicinal product packaging

Directive 2001/83/EC discusses European regulations on labelling. In accordance with Article 54(n), the outer packaging of ...

Policy document | 10-05-2019

Declaration on modification of information in the printed SmPC and package leaflet pertaining to patented indications

Form | 01-05-2019